← Evidence map

ArticlePharmaceuticals (Basel, Switzerland)2022

Augmentation of Antidiabetic Activity of Glibenclamide Microspheres Using S-Protected Okra Powered by QbD: Scintigraphy and In Vivo Studies.

Waleed Y Rizg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35455488